New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol. 2007 Oct; 3(10):570-9; quiz 1 p following 589.